“The ability to understand a patient’s physiology at all times in a real-world setting unlocks so much potential. In 15 years, we’ll wonder how we ever approved drugs without continuous data streams” @physIQ's Chris Englerth, @PharmaVoice's Year in Preview
https://t.co/BxsfLvxyL3
@OncoBay has joined the @physIQ Intrepid Partner Program! OncoBay will use physIQ’s technology to continuously monitor #cancer patients. By using physIQ, OncoBay could transform oncology care.
https://t.co/6KQ2DSnW9U
#CRO#clinicaltrials#oncology
@physIQ’s Intrepid Partner Program enables the #lifesciences solutions ecosystem to deliver next generation #patientinsights, powered by high fidelity medical grade biosensor data streams, providing a distinct advantage to its members.
https://t.co/SzQF3cuKAs
I’m excited to announce that Jason Luke, MD of UPMC has been appointed to @physIQ’s Medical Advisory Board. He has extensive immuno-oncology expertise & will provide physIQ with his skilled counsel. We’re thrilled & honored to have him on our growing TEAM.
https://t.co/WgPy74hkUv
We are pleased to announce that Jason Luke, MD, FACP, a recognized expert in immuno-oncology, has been appointed to @physIQ’s Medical Advisory Board. Dr. Luke will provide expert medical counsel and we could not be more thrilled to welcome him to the TEAM!
https://t.co/lXfTfR3rsN
Very exciting news issued this morning! @physIQ is strategically collaborating with @InCardaThera and @SyneosHealth in a highly innovative study to provide an easier and more convenient treatment for patients with AFib.
https://t.co/Pq9lZoDJtg
Michael Neeb, a trailblazing leader in #healthcare transformation, has joined @PhysIQ as a Special Advisor. We’re thrilled to have his visionary leadership and knowledge to support our mission to improve health outcomes while reducing cost.
https://t.co/b9g5YlOCdu
I am pleased to announce that Michael Neeb has joined @PhysIQ as a Special Advisor. He shares our passion for creating world class healthcare solutions derived from a fundamental interest in leveraging medicine & technology to improve the human condition.
https://t.co/b9g5YlOCdu
Join clinical and therapeutic experts from @SyneosHealth and @PhysIQ as they review the key use cases and measurable benefits generated by #wearable biosensors in #clinicaltrials.
Register for the #webinar today: https://t.co/82krEN3pM8
Biosensors and digital endpoints are becoming a standard component of #clinicaltrials. That is why @PhysIQ is so excited to announce our collaboration with @Science37x that will deliver on the potential of faster, better clinical trials.
https://t.co/I6RkKhuOnc
Can’t wait for #SCOPE2022 next week in Orlando. If you’re attending and would like to meet with the team and learn how @PhysIQ is transforming #healthcare, please reach out.
@PhysIQ published a peer-reviewed paper highlighting the results of a first-of-its kind #COVID19 Decompensation Index that identifies early signs of declining health, & may be applicable to other infectious diseases.
Funded by @NIH & supported by @UIHealth
https://t.co/H8MNQNJthi
Very excited to partner with the prestigious Purdue University once again to co-develop a viral detection algorithm for smartwatches. The ties between @PhysIQ and Purdue grow stronger by the day!
https://t.co/CKMao1jYgd
@PurdueResFound#smartwatches#COVID19#digitalhealth
Very excited to attend the #HLTH2021 conference next week. Be sure to stop by and see @PhysIQ at the @MATTERhealth Pavilion (1347-17) - hope to see you there!
As John and Gary come aboard our Leadership team, they will play a critical role in @PhysIQ's expansion strategy and help drive the deployment of the physIQ platform to #healthcare systems and provider groups, #lifesciences and #pharma companies worldwide.
https://t.co/9hSK94QyrV
@PhysIQ's leadership TEAM is growing!
-Gary Manning as SVP & GM of Healthcare Delivery
-John Varaklis as Chief Strategy Officer
Both passionate & energetic leaders with outstanding dedication & track records. I could not be happier to add them to our TEAM!
https://t.co/9hSK94QyrV